{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:49:05Z","timestamp":1764172145727},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s00198-016-3568-9","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T15:58:19Z","timestamp":1458662299000},"page":"2577-2583","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Increased risk of strontium ranelate-related SJS\/TEN is associated with HLA"],"prefix":"10.1007","volume":"27","author":[{"given":"H. Y.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. X.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. L.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. K.","family":"Tay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M. F.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z. W.","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. B.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. C.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,22]]},"reference":[{"key":"3568_CR1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","volume":"350","author":"PJ Meunier","year":"2004","unstructured":"Meunier PJ, Roux C, Seeman E, Ortolani S, Badurski JE, Spector TD, Cannata J, Balogh A, Lemmel EM, Pors-Nielsen S, Rizzoli R, Genant HK, Reginster JY (2004) The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 350:459\u201368","journal-title":"N Engl J Med"},{"key":"3568_CR2","first-page":"2060","volume":"87","author":"PJ Meunier","year":"2006","unstructured":"Meunier PJ, Slosman DO, Delmas PD, Sebert JL, Brandi ML, Albanese C, Lorenc R, Pors-Nielsen S, De Vernejoul MC, Roces A, Reginster JY (2006) Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis\u2014a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 87:2060\u20136","journal-title":"J Clin Endocrinol Metab"},{"key":"3568_CR3","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/bmj.330.7505.1400","volume":"330","author":"I Fogelman","year":"2005","unstructured":"Fogelman I, Blake GM (2005) Strontium ranelate for the treatment of osteoporosis. BMJ 330:1400\u20131","journal-title":"BMJ"},{"key":"3568_CR4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.23461","volume":"58","author":"JY Reginster","year":"2008","unstructured":"Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, Spector TD, Brixen K, Goemaere S, Cormier C, Balogh A, Delmas PD, Meunier PJ (2008) Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum 58:1687\u201395","journal-title":"Arthritis Rheum"},{"key":"3568_CR5","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","volume":"90","author":"JY Reginster","year":"2005","unstructured":"Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C, Devogelaer JP, Curiel MD, Sawicki A, Goemaere S, Sorensen OH, Felsenberg D, Meunier PJ (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90:2816\u201322","journal-title":"J Clin Endocrinol Metab"},{"key":"3568_CR6","unstructured":"EMEA recommends changes in the product information for Protelos\/Osseor due to the risk of severe hypersensitivity reactions. Press Release (2007). http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2009\/11\/news_detail_000413.jsp&mid=WC0b01ac058004d5c1 . Accessed on 3 Nov 2015"},{"key":"3568_CR7","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00198-013-2265-1","volume":"24","author":"P Cacoub","year":"2013","unstructured":"Cacoub P, Descamps V, Meyer O et al (2013) Drug rash with eosinophilia and systemic symptoms (DRESS) in patients receiving strontium ranelate. Osteoporos Int 24:1751\u20131757","journal-title":"Osteoporos Int"},{"key":"3568_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00198-008-0677-0","volume":"20","author":"HY Lee","year":"2009","unstructured":"Lee HY, Lie D, Lim KS, Thirumoorthy T, Pang SM (2009) Strontium ranelate-induced toxic epidermal necrolysis in a patient with post-menopausal osteoporosis. Osteoporos Int 20:161\u20132","journal-title":"Osteoporos Int"},{"key":"3568_CR9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00198-014-2688-3","volume":"25","author":"CY Yang","year":"2014","unstructured":"Yang CY, Chen CH, Wang HY, Hsiao HL, Hsioa YH, Chung WH (2014) Strontium ranelate related Stevens-Johnson syndrome: a case report. Osteoporos Int 25:1813\u20136","journal-title":"Osteoporos Int"},{"key":"3568_CR10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.47102\/annals-acadmedsg.V40N11p510","volume":"40","author":"KW Tan","year":"2011","unstructured":"Tan KW, Wang YS, Tay YK (2011) Stevens-Johnson syndrome due to strontium ranelate. Ann Acad Med Singapore 40:510\u20131","journal-title":"Ann Acad Med Singapore"},{"key":"3568_CR11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern R (1994) Severe adverse cutaneous reactions to drugs. N Engl J Med 331:1272\u201385","journal-title":"N Engl J Med"},{"key":"3568_CR12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) A clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 129:92\u20139","journal-title":"Arch Dermatol"},{"key":"3568_CR13","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","volume":"133","author":"P Sekula","year":"2013","unstructured":"Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, Kardaun S, Sidoroff A, Liss Y, Schumacher M, Roujeau JC, RegiSCAR study group (2013) Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol 133:1197\u2013204","journal-title":"J Invest Dermatol"},{"key":"3568_CR14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SL, Hong HS (2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428:426","journal-title":"Nature"},{"key":"3568_CR15","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, Lin YL, Lan JL, Yang LC, Hong HS, Chen MJ, Lai PC, Wu MS, Chu CY, Wang KH, Chen CH, Fann CS, Wu JY, Chen YT (2005) HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 102:4134\u20139","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3568_CR16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","volume":"364","author":"M McCormack","year":"2011","unstructured":"McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavi\u010di\u016bt\u0117 D, Carrington M, Sills GJ, Marson T, Jia X, de Bakker PI, Chinthapalli K, Molokhia M, Johnson MR, O\u2019Connor GD, Chaila E, Alhusaini S, Shianna KV, Radtke RA, Heinzen EL, Walley N, Pandolfo M, Pichler W, Park BK, Depondt C, Sisodiya SM, Goldstein DB, Deloukas P, Delanty N, Cavalleri GL, Pirmohamed M (2011) HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 364:1134\u201343","journal-title":"N Engl J Med"},{"key":"3568_CR17","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","volume":"369","author":"FR Zhang","year":"2013","unstructured":"Zhang FR, Liu H, Irwanto A, Fu XA, Li Y, Yu GQ et al (2013) HLA-B*13:01 and the dapsone hypersensitivity syndrome. N Engl J Med 369:1620\u20138","journal-title":"N Engl J Med"},{"key":"3568_CR18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2217\/pgs.09.162","volume":"11","author":"SI Hung","year":"2010","unstructured":"Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC, Chu CY, Chen YT (2010) Common risk allele in aromatic anti-epileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 11:349\u201356","journal-title":"Pharmacogenomics"},{"key":"3568_CR19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, Haustein UF, Vieluf D, Roujeau JC, Le Louet H (2010) ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther 88:60\u20138","journal-title":"Clin Pharmacol Ther"},{"key":"3568_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1034\/j.1399-0039.1999.530308.x","volume":"53","author":"S Pozzi","year":"1999","unstructured":"Pozzi S, Longo A, Ferrara GB (1999) HLA-B locus sequence-based typing. Tissue Antigens 53:275\u201381","journal-title":"Tissue Antigens"},{"key":"3568_CR21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.0001-2815.2004.00214.x","volume":"63","author":"DC Sayer","year":"2004","unstructured":"Sayer DC, Whidborne R, De Santis D, Rozemuller EH, Christiansen FT, Tilanus MG (2004) A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLA-DRB3,4,5. Tissue Antigens 63:412\u201323","journal-title":"Tissue Antigens"},{"key":"3568_CR22","doi-asserted-by":"publisher","first-page":"16972","DOI":"10.1038\/srep16972","volume":"5","author":"TH Lam","year":"2015","unstructured":"Lam TH, Tay MZ, Wang B, Xiao Z, Ren EC (2015) Intrahaplotypic variants differentiate complex linkage disequilibrium within human MHC haplotypes. Sci Rep 5:16972. doi: 10.1038\/srep16972","journal-title":"Sci Rep"},{"key":"3568_CR23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","volume":"358","author":"S Mallal","year":"2008","unstructured":"Mallal S, Phillips E, Carosi G et al (2008) HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 358:568\u201379","journal-title":"N Engl J Med"},{"key":"3568_CR24","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1289\/ehp.10325","volume":"115","author":"H Li","year":"2007","unstructured":"Li H, Dai Y, Huang H, Li L, Leng S, Cheng J, Niu Y, Duan H, Liu Q, Zhang X, Huang X, Xie J, Feng Z, Wang J, He J, Zheng Y (2007) HLA-B*1301 as a biomarker for genetic susceptibility to hypersensitivity dermatitis induced by trichloroethylene among workers in China. Environ Health Perspect 115:1553\u20136","journal-title":"Environ Health Perspect"},{"key":"3568_CR25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","volume":"41","author":"AK Daly","year":"2009","unstructured":"Daly AK, Donaldson PT, Bhatnagar P et al (2009) HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 41:816\u20139","journal-title":"Nat Genet"},{"key":"3568_CR26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.tpj.6500442","volume":"8","author":"K Hirata","year":"2008","unstructured":"Hirata K, Takagi H, Yamamoto M, Matsumoto T, Nishiya T, Mori K, Shimizu S, Masumoto H, Okutani Y (2008) Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case\u2013control study. Pharmacogenomics J 8:29\u201333","journal-title":"Pharmacogenomics J"},{"key":"3568_CR27","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/ncomms5757","volume":"5","author":"JI Goldstein","year":"2014","unstructured":"Goldstein JI, Jarskog LF, Hilliard C et al (2014) Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nature Commun 5:4757","journal-title":"Nature Commun"},{"key":"3568_CR28","first-page":"1063","volume":"135","author":"CH Lim","year":"2014","unstructured":"Lim CH, Chen JK, Ko TM, Wei CY, Yu JY, Chung WH, Chen SY, Liao YD, Hung SI, Chen YT (2014) Immunologic basis for allopurinol-induced SCARs: HLA-B*58:01 restricted activation of drug-specific T cells and molecular interaction. J Allerg Clin Immunol 135:1063\u20135","journal-title":"J Allerg Clin Immunol"},{"key":"3568_CR29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2006.12.617","volume":"119","author":"Y Wu","year":"2007","unstructured":"Wu Y, Farrell J, Pirmohamed M, Park BK, Naisbitt DJ (2007) Generation and characterization of antigen specific CD4+, CD8+, and CD4\u2009+\u2009CD8+ T cell clones from patients with carbamazepine hypersensitivity. J Allerg Clin Immunol 119:973\u201381","journal-title":"J Allerg Clin Immunol"},{"key":"3568_CR30","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/tpj.2013.46","volume":"14","author":"DS Toh","year":"2014","unstructured":"Toh DS, Tan LL, Aw DC, Pang SM, Lim SH, Thirumoorthy T, Lee HY, Tay YK, Tan SK, Vasudevan A, Lateef A, Chong YY, Chan YC, Loke C, Chan CL, Koay ES, Ren EC, Lee EJD, Sung C (2014) Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study. Pharmacogenomics J 14:316\u201321","journal-title":"Pharmacogenomics J"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3568-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-016-3568-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-016-3568-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:29:11Z","timestamp":1692264551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-016-3568-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,22]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["3568"],"URL":"https:\/\/doi.org\/10.1007\/s00198-016-3568-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,22]]}}}